Correlation Between CERo Therapeutics and Opus Genetics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CERo Therapeutics and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CERo Therapeutics and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CERo Therapeutics Holdings and Opus Genetics,, you can compare the effects of market volatilities on CERo Therapeutics and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CERo Therapeutics with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of CERo Therapeutics and Opus Genetics,.

Diversification Opportunities for CERo Therapeutics and Opus Genetics,

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between CERo and Opus is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding CERo Therapeutics Holdings and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and CERo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CERo Therapeutics Holdings are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of CERo Therapeutics i.e., CERo Therapeutics and Opus Genetics, go up and down completely randomly.

Pair Corralation between CERo Therapeutics and Opus Genetics,

Assuming the 90 days horizon CERo Therapeutics Holdings is expected to generate 3.74 times more return on investment than Opus Genetics,. However, CERo Therapeutics is 3.74 times more volatile than Opus Genetics,. It trades about 0.06 of its potential returns per unit of risk. Opus Genetics, is currently generating about 0.09 per unit of risk. If you would invest  2.39  in CERo Therapeutics Holdings on October 21, 2024 and sell it today you would lose (0.85) from holding CERo Therapeutics Holdings or give up 35.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CERo Therapeutics Holdings  vs.  Opus Genetics,

 Performance 
       Timeline  
CERo Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Opus Genetics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Opus Genetics, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

CERo Therapeutics and Opus Genetics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CERo Therapeutics and Opus Genetics,

The main advantage of trading using opposite CERo Therapeutics and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CERo Therapeutics position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.
The idea behind CERo Therapeutics Holdings and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities